PARK STREET SURGERY
PARK STREET, BOOTLE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 35 | 52 | 67.3% | |
| HF 4 | 2011 | 38 | 53 | 71.7% | |
| HF 4 | 2012 | 33 | 44 | 75.0% | |
| HF 4 | 2013 | 33 | 42 | 78.6% | |
| HF004 | 2014 | 16 | 19 | 84.2% | |
| HF004 | 2015 | 30 | 35 | 85.7% | |
| HF004 | 2016 | 38 | 42 | 90.5% | |
| HF004 | 2017 | 35 | 40 | 87.5% | |
| HF004 | 2018 | 41 | 47 | 87.2% | |
| HF004 | 2019 | 40 | 49 | 81.6% | |
| HF004 | 2020 | 37 | 41 | 90.2% | |
| HF006 | 2021 | 52 | 58 | 89.7% | |
| HF006 | 2022 | 43 | 50 | 86.0% | |
| HF006 | 2023 | 51 | 51 | 100.0% |
